Listed

Fortress Biotech, Inc.

FBIONasdaqCIK 1429260HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$18.7m, Q2 FY2026
Operating income−$10.0m, Q2 FY2026
Net income−$468.0k, Q2 FY2026
Fortress Biotech, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m34.8Revenue, Q3 FY2023, three months to 2023-09-30$34.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure19.9Revenue, Q4 FY2023, three months to 2023-12-31$19.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figure13.0Revenue, Q1 FY2024, three months to 2024-03-31$13.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-05-15, accession 0001558370-24-008299.Report this figure14.9Revenue, Q2 FY2024, three months to 2024-06-30$14.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure14.6Revenue, Q3 FY2024, three months to 2024-09-30$14.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure15.1Revenue, Q4 FY2024, three months to 2024-12-31$15.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure13.1Revenue, Q1 FY2025, three months to 2025-03-31$13.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure16.4Revenue, Q2 FY2025, three months to 2025-06-30$16.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure17.6Revenue, Q3 FY2025, three months to 2025-09-30$17.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure16.1Revenue, Q4 FY2025, three months to 2025-12-31$16.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure16.0Revenue, Q1 FY2026, three months to 2026-03-31$16.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure18.7Revenue, Q2 FY2026, three months to 2026-06-30$18.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Cost of revenue$m6.4Cost of revenue, Q3 FY2023, three months to 2023-09-30$6.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure2.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$2.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figure6.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$6.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure5.7Cost of revenue, Q2 FY2024, three months to 2024-06-30$5.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure4.5Cost of revenue, Q3 FY2024, three months to 2024-09-30$4.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure4.7Cost of revenue, Q4 FY2024, three months to 2024-12-31$4.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure4.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$4.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure4.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$4.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure5.8Cost of revenue, Q3 FY2025, three months to 2025-09-30$5.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure5.4Cost of revenue, Q4 FY2025, three months to 2025-12-31$5.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure6.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$6.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure6.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$6.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m20.3Research and development, Q3 FY2023, three months to 2023-09-30$20.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure14.1Research and development, Q4 FY2023, three months to 2023-12-31$14.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2024-03-28, accession 0001558370-24-004272. Derived: 12-month figure less the 9-month figure.Report this figure24.8Research and development, Q1 FY2024, three months to 2024-03-31$24.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-05-15, accession 0001558370-24-008299.Report this figure12.7Research and development, Q2 FY2024, three months to 2024-06-30$12.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-08-13, accession 0001558370-24-012063.Report this figure9.4Research and development, Q3 FY2024, three months to 2024-09-30$9.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m21.7Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$21.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure19.5Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$19.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figure17.9Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$17.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure20.8Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$20.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure22.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$22.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure26.9Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$26.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure25.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$25.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure38.8Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$38.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure17.4Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$17.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure14.7Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$14.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure15.9Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$15.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure20.8Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$20.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Operating income$m(13.8)Operating income, Q3 FY2023, three months to 2023-09-30−$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure(19.6)Operating income, Q4 FY2023, three months to 2023-12-31−$19.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figure(36.6)Operating income, Q1 FY2024, three months to 2024-03-31−$36.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure(27.8)Operating income, Q2 FY2024, three months to 2024-06-30−$27.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure(22.1)Operating income, Q3 FY2024, three months to 2024-09-30−$22.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure(23.8)Operating income, Q4 FY2024, three months to 2024-12-31−$23.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure(22.3)Operating income, Q1 FY2025, three months to 2025-03-31−$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure(36.5)Operating income, Q2 FY2025, three months to 2025-06-30−$36.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure(6.8)Operating income, Q3 FY2025, three months to 2025-09-30−$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure(4.8)Operating income, Q4 FY2025, three months to 2025-12-31−$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure(7.7)Operating income, Q1 FY2026, three months to 2026-03-31−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure(10.0)Operating income, Q2 FY2026, three months to 2026-06-30−$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.1Income tax, Q3 FY2023, three months to 2023-09-30$141.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure0.4Income tax, Q4 FY2023, three months to 2023-12-31$379.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-09-30$69.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure0.3Income tax, Q4 FY2024, three months to 2024-12-31$336.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$26.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure(0.8)Income tax, Q4 FY2025, three months to 2025-12-31−$816.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure5.1Income tax, Q1 FY2026, three months to 2026-03-31$5.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure0.3Income tax, Q2 FY2026, three months to 2026-06-30$320.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Net income$m(5.0)Net income, Q3 FY2023, three months to 2023-09-30−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure(9.3)Net income, Q4 FY2023, three months to 2023-12-31−$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figure(15.4)Net income, Q1 FY2024, three months to 2024-03-31−$15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure(10.9)Net income, Q2 FY2024, three months to 2024-06-30−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure(12.9)Net income, Q3 FY2024, three months to 2024-09-30−$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure(6.8)Net income, Q4 FY2024, three months to 2024-12-31−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Net income, Q1 FY2025, three months to 2025-03-31−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure15.5Net income, Q2 FY2025, three months to 2025-06-30$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure5.9Net income, Q3 FY2025, three months to 2025-09-30$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure(3.9)Net income, Q4 FY2025, three months to 2025-12-31−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure110Net income, Q1 FY2026, three months to 2026-03-31$110.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure(0.5)Net income, Q2 FY2026, three months to 2026-06-30−$468.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Diluted EPS$ per share(0.94)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figurenot reported(1.04)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure(0.73)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure(0.76)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figurenot reported(0.48)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure0.45Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure0.11Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figurenot reported2.82Diluted EPS, Q1 FY2026, three months to 2026-03-31$2.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Basic EPS$ per share(0.94)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figurenot reported(1.04)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure(0.73)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure(0.76)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figurenot reported(0.48)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure0.50Basic EPS, Q2 FY2025, three months to 2025-06-30$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure0.13Basic EPS, Q3 FY2025, three months to 2025-09-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figurenot reported3.44Basic EPS, Q1 FY2026, three months to 2026-03-31$3.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure

Balance sheet

Cash and equivalents$196.6m, Q2 FY2026
Long-term debt$35.0m, Q2 FY2026
Shareholders' equity$164.1m, Q2 FY2026
Fortress Biotech, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m72.3Cash and equivalents, Q3 FY2023, at 2023-09-30$72.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure80.9Cash and equivalents, FY2023, at 2023-12-31$80.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001558370-25-004160.Report this figure83.8Cash and equivalents, Q1 FY2024, at 2024-03-31$83.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure76.2Cash and equivalents, Q2 FY2024, at 2024-06-30$76.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure58.9Cash and equivalents, Q3 FY2024, at 2024-09-30$58.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure57.3Cash and equivalents, FY2024, at 2024-12-31$57.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001104659-26-037874.Report this figure91.3Cash and equivalents, Q1 FY2025, at 2025-03-31$91.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure74.4Cash and equivalents, Q2 FY2025, at 2025-06-30$74.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure86.2Cash and equivalents, Q3 FY2025, at 2025-09-30$86.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure79.4Cash and equivalents, FY2025, at 2025-12-31$79.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure256Cash and equivalents, Q1 FY2026, at 2026-03-31$255.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure197Cash and equivalents, Q2 FY2026, at 2026-06-30$196.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Current assets$m97.8Current assets, Q3 FY2023, at 2023-09-30$97.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019050.Report this figure117Current assets, FY2023, at 2023-12-31$117.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001558370-25-004160.Report this figure117Current assets, Q1 FY2024, at 2024-03-31$116.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001558370-24-008299.Report this figure103Current assets, Q2 FY2024, at 2024-06-30$103.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001558370-24-012063.Report this figure86.3Current assets, Q3 FY2024, at 2024-09-30$86.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure90.4Current assets, FY2024, at 2024-12-31$90.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001104659-26-037874.Report this figure127Current assets, Q1 FY2025, at 2025-03-31$126.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure110Current assets, Q2 FY2025, at 2025-06-30$110.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure119Current assets, Q3 FY2025, at 2025-09-30$118.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure124Current assets, FY2025, at 2025-12-31$123.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure295Current assets, Q1 FY2026, at 2026-03-31$295.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure246Current assets, Q2 FY2026, at 2026-06-30$245.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Total assets$m151Total assets, Q3 FY2023, at 2023-09-30$150.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001558370-23-019050.Report this figure168Total assets, FY2023, at 2023-12-31$167.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001558370-25-004160.Report this figure165Total assets, Q1 FY2024, at 2024-03-31$164.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure146Total assets, Q2 FY2024, at 2024-06-30$145.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure127Total assets, Q3 FY2024, at 2024-09-30$127.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure144Total assets, FY2024, at 2024-12-31$144.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001104659-26-037874.Report this figure178Total assets, Q1 FY2025, at 2025-03-31$178.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure160Total assets, Q2 FY2025, at 2025-06-30$159.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure181Total assets, Q3 FY2025, at 2025-09-30$181.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure186Total assets, FY2025, at 2025-12-31$185.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure357Total assets, Q1 FY2026, at 2026-03-31$356.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure317Total assets, Q2 FY2026, at 2026-06-30$316.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Current liabilities$m97.4Current liabilities, Q3 FY2023, at 2023-09-30$97.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019050.Report this figure84.9Current liabilities, FY2023, at 2023-12-31$84.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001558370-25-004160.Report this figure87.7Current liabilities, Q1 FY2024, at 2024-03-31$87.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001558370-24-008299.Report this figure75.5Current liabilities, Q2 FY2024, at 2024-06-30$75.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001558370-24-012063.Report this figure70.3Current liabilities, Q3 FY2024, at 2024-09-30$70.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure71.4Current liabilities, FY2024, at 2024-12-31$71.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001104659-26-037874.Report this figure73.7Current liabilities, Q1 FY2025, at 2025-03-31$73.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure57.5Current liabilities, Q2 FY2025, at 2025-06-30$57.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure54.1Current liabilities, Q3 FY2025, at 2025-09-30$54.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure49.7Current liabilities, FY2025, at 2025-12-31$49.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure103Current liabilities, Q1 FY2026, at 2026-03-31$103.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure62.0Current liabilities, Q2 FY2026, at 2026-06-30$62.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Total liabilities$m164Total liabilities, Q3 FY2023, at 2023-09-30$163.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001558370-23-019050.Report this figure166Total liabilities, FY2023, at 2023-12-31$165.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001558370-25-004160.Report this figure169Total liabilities, Q1 FY2024, at 2024-03-31$168.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001558370-24-008299.Report this figure160Total liabilities, Q2 FY2024, at 2024-06-30$160.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001558370-24-012063.Report this figure140Total liabilities, Q3 FY2024, at 2024-09-30$139.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure146Total liabilities, FY2024, at 2024-12-31$145.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001104659-26-037874.Report this figure146Total liabilities, Q1 FY2025, at 2025-03-31$145.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure123Total liabilities, Q2 FY2025, at 2025-06-30$122.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure116Total liabilities, Q3 FY2025, at 2025-09-30$116.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure123Total liabilities, FY2025, at 2025-12-31$123.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure155Total liabilities, Q1 FY2026, at 2026-03-31$154.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure111Total liabilities, Q2 FY2026, at 2026-06-30$110.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Long-term debt$m45.8Long-term debt, Q3 FY2023, at 2023-09-30$45.8m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-14, accession 0001558370-23-019050.Report this figure60.9Long-term debt, FY2023, at 2023-12-31$60.9m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-31, accession 0001558370-25-004160.Report this figure61.4Long-term debt, Q1 FY2024, at 2024-03-31$61.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-15, accession 0001558370-24-008299.Report this figure67.0Long-term debt, Q2 FY2024, at 2024-06-30$67.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-13, accession 0001558370-24-012063.Report this figure52.5Long-term debt, Q3 FY2024, at 2024-09-30$52.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure58.0Long-term debt, FY2024, at 2024-12-31$58.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-31, accession 0001104659-26-037874.Report this figure56.4Long-term debt, Q1 FY2025, at 2025-03-31$56.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure50.0Long-term debt, Q2 FY2025, at 2025-06-30$50.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure47.8Long-term debt, Q3 FY2025, at 2025-09-30$47.8m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure54.5Long-term debt, FY2025, at 2025-12-31$54.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure37.5Long-term debt, Q1 FY2026, at 2026-03-31$37.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure35.0Long-term debt, Q2 FY2026, at 2026-06-30$35.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure
Shareholders' equity$m16.7Shareholders' equity, Q3 FY2023, at 2023-09-30$16.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-14, accession 0001558370-23-019050.Report this figure22.5Shareholders' equity, FY2023, at 2023-12-31$22.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-31, accession 0001558370-25-004160.Report this figure23.0Shareholders' equity, Q1 FY2024, at 2024-03-31$23.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-15, accession 0001558370-24-008299.Report this figure17.9Shareholders' equity, Q2 FY2024, at 2024-06-30$17.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-13, accession 0001558370-24-012063.Report this figure21.2Shareholders' equity, Q3 FY2024, at 2024-09-30$21.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure22.7Shareholders' equity, FY2024, at 2024-12-31$22.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001104659-26-037874.Report this figure22.3Shareholders' equity, Q1 FY2025, at 2025-03-31$22.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure43.9Shareholders' equity, Q2 FY2025, at 2025-06-30$43.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure55.9Shareholders' equity, Q3 FY2025, at 2025-09-30$55.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure49.9Shareholders' equity, FY2025, at 2025-12-31$49.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure162Shareholders' equity, Q1 FY2026, at 2026-03-31$162.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure164Shareholders' equity, Q2 FY2026, at 2026-06-30$164.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure

Cash flow

Operating cash flow−$59.3m, Q2 FY2026
Capital expenditure$0, Q4 FY2024
Fortress Biotech, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(16.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001558370-24-015740. Derived: 9-month figure less the 6-month figure.Report this figure(34.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$34.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figure(25.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$25.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure(21.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001558370-25-011570. Derived: 6-month figure less the 3-month figure.Report this figure(20.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$20.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001104659-25-111989. Derived: 9-month figure less the 6-month figure.Report this figure(12.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$12.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure(19.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$19.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure(27.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$27.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095964. Derived: 6-month figure less the 3-month figure.Report this figure(6.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001104659-25-111989. Derived: 9-month figure less the 6-month figure.Report this figure(12.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure204Operating cash flow, Q1 FY2026, three months to 2026-03-31$203.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure(59.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$59.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095964. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001558370-24-015740. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$28.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001558370-24-015740. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Dividends paid$m0.2Dividends paid, Q3 FY2023, three months to 2023-09-30$185.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2024-11-14, accession 0001558370-24-015740. Derived: 9-month figure less the 6-month figure.Report this figure0.2Dividends paid, Q4 FY2023, three months to 2023-12-31$180.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2025-03-31, accession 0001558370-25-004160. Derived: 12-month figure less the 9-month figure.Report this figure0.2Dividends paid, Q1 FY2024, three months to 2024-03-31$176.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure0.2Dividends paid, Q2 FY2024, three months to 2024-06-30$176.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-08-14, accession 0001558370-25-011570. Derived: 6-month figure less the 3-month figure.Report this figure0.2Dividends paid, Q3 FY2024, three months to 2024-09-30$176.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-11-14, accession 0001104659-25-111989. Derived: 9-month figure less the 6-month figure.Report this figure0.2Dividends paid, Q4 FY2024, three months to 2024-12-31$166.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure0.2Dividends paid, Q1 FY2025, three months to 2025-03-31$166.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure0.2Dividends paid, Q2 FY2025, three months to 2025-06-30$166.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-08-13, accession 0001104659-26-095964. Derived: 6-month figure less the 3-month figure.Report this figure0.2Dividends paid, Q3 FY2025, three months to 2025-09-30$166.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-11-14, accession 0001104659-25-111989. Derived: 9-month figure less the 6-month figure.Report this figure0.2Dividends paid, Q4 FY2025, three months to 2025-12-31$166.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-03-31, accession 0001104659-26-037874. Derived: 12-month figure less the 9-month figure.Report this figure0.0Dividends paid, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figurenot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)31.79m, Q2 FY2026
Fortress Biotech, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares6.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-305,961,663 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001558370-23-019050.Report this figure102Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31101,885,648 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-15, accession 0001558370-23-009855.Report this figure7.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-307,377,332 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001558370-24-012063.Report this figure7.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-307,498,653 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001558370-24-015740.Report this figure17.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3117,151,945 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001558370-25-007898.Report this figure18.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3018,316,874 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001558370-25-011570.Report this figure19.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3019,697,290 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure26.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3126,450,218 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure29.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3029,824,182 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure33.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3033,100,961 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001104659-25-111989.Report this figure38.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3138,412,716 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001104659-26-061233.Report this figure31.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3031,791,173 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095964.Report this figure

Shares outstanding: 82.47mShares outstanding, period not labelled, at 2020-05-0782,474,127 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2020-05-11, accession 0001104659-20-059592.Report this figure at May 7, 2020, from the cover of the 10-Q filed May 11, 2020.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.